#Japan #Bioinformatics #Fukuoka #Iwai Chemical #Cell Innovator

Iwai Chemical Pharmaceuticals Acquires Cell Innovator: A Game Changer in Bioinformatics

In a significant move to bolster its life sciences focus, Iwai Chemical Pharmaceuticals Co., Ltd., located in Chuo-ku, Tokyo, has officially acquired 100% of the shares in Cell Innovator Co., Ltd., based in Fukuoka City, effective June 2, 2026. This acquisition aims to significantly enhance the research support system in the bioinformatics sector.

An Innovative Synergy

Iwai Chemical, a specialist in reagents and scientific instruments, looks forward to merging its sales expertise and resources with Cell Innovator's cutting-edge analytical services. This partnership is shaped around the formula: Iwai Chemical (Product) x Cell Innovator (Intelligence) = Total Solution (Value). The goal is not just integration, but a pathway to creating innovative solutions that provide higher value to researchers in the life sciences field.

About Cell Innovator

Founded as a venture company out of Kyushu University, Cell Innovator brings almost two decades of serving the life sciences community with high-quality analytical support services. With a strong commitment to addressing researchers' challenges, their offerings range from experimental planning consultations and figure preparations to supporting manuscript submissions and providing a full year of post-delivery support at no extra cost. Their flexible approach to custom analyses is particularly appreciated by clients. This steadfast dedication to quality positions Cell Innovator as a key player in the academic and research landscape.

Iwai Chemical Pharmaceuticals: A Vision for the Future

Iwai Chemical embraces the motto of ‘Creating the Future Together with Researchers.’ Its focus has traditionally been on the sale of reagents and scientific instruments, ensuring that customers receive tailored support in their research efforts. With plans to launch a new “Instrumentation/BI Team” reporting directly to the president by October 2024, Iwai Chemical is set to deepen its engagement in the bioinformatics business and venture into new territories.

The acquisition allows Iwai Chemical to leverage its existing sales network to introduce Cell Innovator's services to a broader audience, especially in the Kanto region. Furthermore, the synergy generated will enhance the service line and operational frameworks within the bioinformatics sector, providing better support for life science research.

Commitment to Existing Relationships

While the acquisition opens doors to new opportunities, both companies prioritize maintaining trust with their current customers and partner companies. They are committed to respecting existing relationships and ensuring that there are no changes to ongoing transactions or supply chains. The goal is to enhance service quality while building upon established partnerships.

Leadership Structure Post-Acquisition

Following the stock acquisition, the leadership team at Cell Innovator will be led by President Yoshiko Iwai and Executive Officer Kaori Yasuda, ensuring a seamless transition and continued innovation.

Company Overview

• - Iwai Chemical Pharmaceuticals Co., Ltd.

Address: 3-2-10 Nihonbashi Honmachi, Chuo-ku, Tokyo
Business: Sales of reagents, scientific instruments, and bioinformatics-related services
Website: iwai-chem.co.jp

• - Cell Innovator Co., Ltd.

Address: 4th Floor, Collabo Station I, 3-1-1 Maeda, Higashi-ku, Fukuoka City
Business: Contract and consulting services in bioinformatics (gene expression, proteomics analysis, etc.)
Website: cell-innovator.com

For Media Inquiries

Contact Iwai Chemical Pharmaceuticals (Management Division) at 03-3241-2572 or through the inquiry form.
For inquiries regarding Cell Innovator, contact at 092-986-5427 or through the inquiry form.